Multicenter Evaluation of HemoTypeSC as a Point-of-Care Sickle Cell Disease Rapid Diagnostic Test for Newborns and Adults Across India

201930 citationsJournal Article

Authors

We conclude that the rapid, point-of-care testing device HemoTypeSC test is suitable for population and newborn screening for the HbS phenotype.

Published in: American Journal of Clinical Pathology

Volume 153, Issue 1, pp. 82-87

Field-Weighted Citation Impact: 1.14